PMVP
PMV Pharmaceuticals, Inc.
$1.24
+0.04 (+2.90%)
At close · Jul 7
Market Cap
$67.73M
Shares
53,331,766
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-05 | 2026-06-04 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-22 | 2026-06-04 | |
| 8-K | 2026-03-06 | — | |
| 10-K | 2026-03-06 | 2025-12-31 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-09-10 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-09 | 2025-06-05 | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| 8-K | 2025-05-09 | — | |
| DEF 14A | 2025-04-25 | 2025-06-05 | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-08-08 | 2024-08-05 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-06-07 | 2024-06-06 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | 2024-06-06 | |
| 8-K | 2024-02-29 | — | |
| 10-K | 2024-02-29 | 2023-12-31 | |
| 8-K | 2024-01-18 | — | |
| 8-K | 2024-01-05 | 2024-01-04 | |
| 8-K | 2023-11-09 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-10-12 | — | |
| 8-K | 2023-10-11 | — | |
| 8-K | 2023-08-09 | — | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-06-09 | 2023-06-08 | |
| 8-K | 2023-05-10 | — | |
| 10-Q | 2023-05-10 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 2023-06-08 | |
| 8-K | 2023-04-28 | 2023-04-24 | |
| 10-K | 2023-03-01 | 2022-12-31 | |
| 8-K | 2023-03-01 | — | |
| 10-Q | 2022-11-08 | 2022-09-30 | |
| 8-K | 2022-11-08 | — | |
| 8-K | 2022-11-04 | 2022-11-03 | |
| 8-K | 2022-08-09 | — | |
| 10-Q | 2022-08-09 | 2022-06-30 | |
| 8-K | 2022-06-08 | 2022-06-07 | |
| 8-K | 2022-06-06 | 2022-06-02 | |
| 8-K | 2022-05-26 | — |
Showing 1–50 of 71 filings